EREG antibody, Unconjugated, Rabbit, Polyclonal

Produktübersicht

• Artikelname: EREG antibody, Unconjugated, Rabbit, Polyclonal
• Artikelnummer: BYT-ORB378205-IH
• Hersteller Artikelnummer: orb378205
• Alternativnummer: BYT-ORB378205-100
• Hersteller: Biorbyt
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: IHC-P, WB
• Spezies Reaktivität: Human, Mouse, Rat
• Immunogen: KLH conjugated synthetic peptide derived from human EREG. Please contact us for the exact immunogen sequence. The peptide is available as orb12967.
• Konjugation: Unconjugated

Produktbeschreibung

EREG antibody

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: - 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
• Molekulargewicht: 19 kDa
• Reinheit: Polyclonal antibodies are purified by peptide affinity chromatography
• Formulierung: 10 mM PBS, 0.02% sodium azide
• Target-Kategorie: EREG

Anwendungsbeschreibung

• Application Verdünnung: IHC-P: 1:100-800, WB: 1:200-2000

Bilder

Immunohistochemical staining of paraffin embedded human liver cancer tissue using EREG antibody (primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human gastric cancer tissue using EREG antibody (primary antibody at 2.5 ug/ml)

IHC-P staining of human gastric cancer tissue using anti- EREG (dilution at 2.5 ug/ml)

Immunohistochemical staining of human prostatic cancer tissue using anti- EREG (dilution of primary antibody - 2.5 ug/ml)

IHC-P image of rat liver tissue using EREG antibody (dilution of primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human colon cancer tissue using anti- EREG (primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human colon cancer tissue using anti- EREG (primary antibody at 2.5 ug/ml)

Wesstern blot analysis of human lung cancer (lane 1), human breast cancer (lane 2), human thyroid cancer (lane 3), human endometrial cancer (lane 4), human ovarian cancer (lane 5), Hela cells (lane 6) using EREG antibody (1 ug/ml)

WB analysis of human lung cancer (lane 1), human breast cancer (lane 2), human thyroid cancer (lane 3), human endometrial cancer (lane 4), human ovarian cancer (lane 5), Hela cells (lane 6) using EREG antibody (1 ug/ml)